Widespread Non-Canonical Epigenetic Modifications in MMTV-NeuT Breast Cancer12

• Published in: Neoplasia (New York, N.Y.) N.Y.), 2015-04, Vol.17 (4), p.348-357
• Main Authors: Felts, Sara J., Van Keulen, Virginia P., Hansen, Michael J., Bell, Michael P., Allen, Kathleen, Belachew, Alem A., Vile, Richard G., Cunningham, Julie M., Hoskin, Tanya L., Pankratz, V. Shane, Pease, Larry R.
• Format: Article
• Language: English
• ISSN: 1522-8002; 1476-5586
• DOI: 10.1016/j.neo.2015.02.006

Breast tumors in (FVB × BALB-NeuT) F1 mice have characteristic loss of chromosome 4 and sporadic loss or gain of other chromosomes. We employed the Illumina GoldenGate genotyping platform to quantitate loss of heterozygosity (LOH) across the genome of primary tumors, revealing strong biases favoring chromosome 4 alleles from the FVB parent. While allelic bias was not observed on other chromosomes, many tumors showed concerted LOH (C-LOH) of all alleles of one or the other parent on sporadic chromosomes, a pattern consistent with cytogenetic observations. Surprisingly, comparison of LOH in tumor samples relative to normal unaffected tissues from these animals revealed significant variegated (stochastic) deviations from heterozygosity (V-LOH) in every tumor genome. Sequence analysis showed expected changes in the allelic frequency of single nucleotide polymorphisms (SNPs) in cases of C-LOH. However, no evidence of LOH due to mutations, small deletions, or gene conversion at the affected SNPs or surrounding DNA was found at loci with V-LOH. Postulating an epigenetic mechanism contributing to V-LOH, we tested whether methylation of template DNA impacts allele detection efficiency using synthetic oligonucleotide templates in an assay mimicking the GoldenGate genotyping format. Methylated templates were systematically over-scored, suggesting that the observed patterns of V-LOH may represent extensive epigenetic DNA modifications across the tumor genomes. As most of the SNPs queried do not contain standard (CpG) methylation targets, we propose that widespread, non-canonical DNA modifications occur during Her2/neuT-driven tumorigenesis.